2011 versus 1911: Many advances made, but old demons remain

December 30, 2010

The lead Editorial in this week's Lancet--the first of 2011--takes a look at the past 100 years in medicine, and examines the journal's first Editorial of 1911, entitled "The Promise of 1911". Many issues that were relevant a century ago remain so today.

The then Lancet editor Squire Sprigge talked of the demon of tuberculosis, and his hopes that "better understanding would one day result in mastery of the disease". Today, tuberculosis continues to blight populations of developing countries worldwide. And nor is it banished even from high-income nations such as the UK, which has seen a steep increase in cases over the past decade.

The social determinants of health, occupational health and workers' compensation all got a mention in the 1911 Editorial, as did the 'quackery' of homoeopathy, echoing modern day sentiments of some people on this issue. Emphasis on syphilis may appear dated, but the 21st century has seen cases on the rise again in high-risk groups in wealthy nations. Cocaine addiction in Canada is highlighted in the 1911 piece, and some leading causes of death in South Africa then--such as tuberculosis, diarrhoea, and respiratory infections--remain so 100 years later.

The importance of modernising medical education doctors was as much in the spotlight then (after a major 1910 report) as it is today, following a recent Lancet Commission into the subject last month. The behaviour of expert medical witnesses and the media was examined by Sprigge. Even medical tourism gets a mention in 1911, and this is extremely relevant in 2011 in light of the media frenzy surrounding the NDM-1 "superbug" and its association with medical tourism (published in Lancet Infectious Diseases this year).

The 2011 Editorial notes how some content in 1911 has been rendered poignant by history. A book review in that issue 100 years ago examined A handbook for medical officers in the field; three years later, World War I would begin. A UK hospital announced plans to acquire an X-ray machine--unaware that, years later, those X-rayed would have a higher risk of developing cancer, in an era before appropriate safeguards were in place. And from Vienna came news about superior health among the city's 180,000 Jewish people, whom a generation later would face lethal persecution.

The 1911 Editorial concludes: "We may in fact, in matters medical, congratulate ourselves upon a hopeful state of affairs and upon the prospect of a sustained forward movement in the year 1911."

The 2011 Editorial concludes: "Between 1911 and 2011 there is much for medicine to be proud of--and also be humble about. New years bring new promise and new opportunities, but some old demons remain."
-end-
The Lancet Press Office. T) +44 (0) 20 7424 4949 E) tony.kirby@lancet.com

For 2011 Editorial see: http://press.thelancet.com/editorials0101.pdf

For 1911 Editorial see: http://press.thelancet.com/editorial1911.pdf

Lancet

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.